$crvs

Corvus Pharmaceuticals' soquelitinib shows promising clinical data and novel ITK inhibition, but faces valuation concerns and scrutiny from short sellers.

About $crvs

Corvus Pharmaceuticals is a biotechnology company focused on developing novel therapeutics.

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Month: [---------] +272%
[--] Months: [---------] +117%
[--] Year: [---------] +57%
1-Year High: [-------] on 2026-01-20
1-Year Low: [-----] on 2025-03-16

Engagements by network (24h): X: [------] YouTube: [--] Reddit: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
1-Year High: [---] on 2026-01-29
1-Year Low: [--] on 2025-03-16

Mentions by network (24h): X: [---] YouTube: [--] Reddit: [--]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning $crvs in the last [--] hours which is down 26% from [---] in the previous [--] hours Daily Average: [--]
1-Year High: [---] on 2026-01-21
1-Year Low: [--] on 2025-03-16

The most influential creators that mention $crvs in the last [--] hours

Creator Rank Followers Posts Engagements
@financebully [--] [-----] [--] [-----]
@tradingsssss [--] [-----] [--] [-----]
@A_May_MD [--] [------] [--] [-----]
@semodough [--] [------] [--] [-----]
@HOThomasWPhelps [--] [-----] [--] [-----]
@seedy19tron [--] [------] [--] [-----]
@BiotechTV [--] [------] [--] [-----]
@ShortSeller [--] [------] [--] [---]
@paxtrader777 [--] [---] [--] [---]
@zethedeuce [--] [---] [--] [---]

View More

Sentiment: 73%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 73%
Daily Average: 92%
[--] Month: 73% +13%
[--] Months: 73% -27%
[--] Year: 73% -22%
1-Year High: 100% on 2025-02-18
1-Year Low: 49% on 2025-10-26

Most Supportive Themes:

Most Critical Themes:

Top $crvs Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"$NKTR $CRVS $NKTR $CRVS don't understand the animosity between the two names both work on tregs and $NKTR's data provides a nice read through to $CRVS drug and vice versa most BPs talk about this and this is being talked about the same way with $ABVX and obefazimod in IBD but a safe $NKTR $CRVS don't understand the animosity between the two names both work on tregs and $NKTR's data provides a nice read through to $CRVS drug and vice versa most BPs talk about this and this is being talked about the same way with $ABVX and obefazimod in IBD but a safe"
X Link @tradingsssss 2026-02-15T00:33Z [----] followers, [----] engagements

"@lfholt nice. $evmn and $nmra now in top [--] ytd. $anl $eras $ibrx $alms $crvs $nika $elvn $catx"
X Link @financebully 2026-02-14T23:35Z [----] followers, [---] engagements

"@mrhighway_y @dbruhzinski3 i'm a fan and investor of $crvs $acrs and $arqt. i also think $apge $kymr $evmn and trex bio have commercial promise in atd. i don't think nktr has commercial promise. the end"
X Link @financebully 2026-02-14T22:56Z [----] followers, [---] engagements

"@semodough 100%. $nktr $crvs will be the leaders in AtD"
X Link @wz2013 2026-02-14T22:34Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing